Vanguard Group Inc Homology Medicines, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.53 - $1.14 $56,631 - $121,811	-106,852 Reduced 5.22%	1,939,590 $1.18 Million
Q4 2022 Feb 10, 2023	BUY	$1.09 - $2.04 $922 - $1,725	846 Added 0.04%	2,046,442 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $181,762 - $352,970	117,266 Added 6.08%	2,045,596 $3.29 Million
Q2 2022 Aug 12, 2022	BUY	$1.39 - $3.12 $200,082 - $449,105	143,944 Added 8.07%	1,928,330 $3.8 Million
Q1 2022 May 13, 2022	SELL	$2.6 - $4.17 $442,876 - $710,305	-170,337 Reduced 8.71%	1,784,386 $5.42 Million

Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $357,262 - $763,599	-98,149 Reduced 4.78%	1,954,723 $7.12 Million
Q3 2021 Nov 12, 2021	SELL	$6.01 - $8.71 $415,946 - $602,810	-69,209 Reduced 3.26%	2,052,872 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$6.02 - $9.64 $12.8 Million - $20.5 Million	2,122,081 New	2,122,081 $15.4 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.